COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
<p dir="ltr">Large scale multi-omics analysis has identified significant differences in the biomarkers between COVID-19 disease and control subjects [1]. These protein panels target biological processes involved in vessel damage, platelet degranulation, the coagulation cascade and th...
محفوظ في:
| المؤلف الرئيسي: | Abu Saleh Md Moin (6189512) (author) |
|---|---|
| مؤلفون آخرون: | Thozhukat Sathyapalan (704787) (author), Stephen L. Atkin (6684368) (author), Alexandra E. Butler (6189536) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
حسب: Abu Saleh Md Moin (6189512)
منشور في: (2021) -
Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
حسب: Abu Saleh Md Moin (6189512)
منشور في: (2021) -
Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
حسب: Abu Saleh Md Moin (6189512)
منشور في: (2021) -
Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight
حسب: Ilhame Diboun (3522413)
منشور في: (2021) -
The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome
حسب: Moaz O. Moursi (17019030)
منشور في: (2023)